Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Richard Pieschl"'
Autor:
Linda J Bristow, Amy E Easton, Yu-Wen Li, Digavalli V Sivarao, Regina Lidge, Kelli M Jones, Debra Post-Munson, Christopher Daly, Nicholas J Lodge, Lizbeth Gallagher, Thaddeus Molski, Richard Pieschl, Ping Chen, Adam Hendricson, Ryan Westphal, James Cook, Christiana Iwuagwu, Daniel Morgan, Yulia Benitex, Dalton King, John E Macor, Robert Zaczek, Richard Olson
Publikováno v:
PLoS ONE, Vol 11, Iss 7, p e0159996 (2016)
The development of alpha7 nicotinic acetylcholine receptor agonists is considered a promising approach for the treatment of cognitive symptoms in schizophrenia patients. In the present studies we characterized the novel agent, (2R)-N-(6-(1H-imidazol-
Externí odkaz:
https://doaj.org/article/cb2d80cbb97446c297511d2d30823d16
Autor:
Debra J. Post-Munson, Ping Chen, Linda J. Bristow, Daniel G. Morgan, Ryan Westphal, Kelli M. Jones, Adam Hendricson, Lizbeth Gallagher, Dalton King, Yulia Benitex, Richard Pieschl, Digavalli V. Sivarao, Christiana I. Iwuagwu, Robert Zaczek, Regina Lidge, Nicholas J. Lodge, John E. Macor, Amy Easton, James H. Cook, Yu-Wen Li, Thaddeus F. Molski, Richard E. Olson, Christopher Daly
Publikováno v:
PLoS ONE
PLoS ONE, Vol 11, Iss 7, p e0159996 (2016)
PLoS ONE, Vol 11, Iss 7, p e0159996 (2016)
The development of alpha7 nicotinic acetylcholine receptor agonists is considered a promising approach for the treatment of cognitive symptoms in schizophrenia patients. In the present studies we characterized the novel agent, (2R)-N-(6-(1H-imidazol-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e845cf9f7d9cd9aa45b681f10cc5d9bb
http://europepmc.org/articles/PMC4965148
http://europepmc.org/articles/PMC4965148